Kalpana S. Reddy, MD

Treating persons with heme malignancies in limited resources settings is extremely challenging. Yet, this is hardly discussed in top venues or forums. I hope you like my editorial The Underrepresented Majority now in @TheLancetHaem thelancet.com/journals/lanha…

French architect and designer Emmanuelle Moureaux's large-scale interactive installation created with thousands of coloured paper cut numerals, known as the 'Forest of Numbers' #WomensArt

Pure erythroid leukemia is characterized by biallelic TP53 inactivation and abnormal p53 expression patterns in de novo and secondary cases @Haematologica haematologica.org/article/view/h…

Defining and treating high-grade B-cell lymphoma, NOS loom.ly/9KKwxDE

Received a call from a community oncologist expressing dismay that his #MDS patient now had two different classifications based on #ICC and #WHO…the reality of academic brutality is that our patients and communities end up paying the price #Thismuststop #Patientscomefirst

The CAP joins dozens of medical associations in the call to halt further Medicare cuts: capatholo.gy/3cVvoil.

haematologica.org/article/view/h… Link to - How I diagnose and treat #CMML @Haematologica | Comprehensive and practical approach to one of the most fascinating neoplasms | Rare diseases are not rare to those afflicted by them| #notMDS #notMPN @MayoCancerCare

👉🏻Diagnosis and Management of AML in Adults: 2022 ELN Recommendations from an International Expert Panel @AML_Hub @ASTCT @ASH_hematology @TheEBMT ashpublications.org/blood/article/…

Our latest perspective: Enhancing the Trajectories of Cancer Health Disparities Research: Improving Clinical Applications of Diversity, Equity, Inclusion, and Accessibility aacrjournals.org/cancerdiscover…

@SocforHemepath @evemariecrane @DanBabuMD @Michael_Kallen_ @MaracajaDLV @nodesallday @JBalakrishnaMD @weinberg_olga It is not open access. Kind of unfair for an “international consensus classification…” @NicoGagelmann

Drumroll please .... the International Consensus Classification of Myeloid Neoplasms and Acute Leukemia: Integrating Morphological, Clinical, and Genomic Data is now available online!!! doi.org/10.1182/blood.… #hemepath #SHupdatebyte

Recurrent splice site mutations affect key diffuse large B-cell lymphoma genes loom.ly/mrIfrYc

Proud to see our grandiose cavalcade of #ctDNA analysis in aggressive LBCLs out in @BloodJournal colors. doi.org/10.1182/blood.… 🧵 Here’s what we learned from our trial by analyzing ordinary plasma samples for their extraordinary content /n

Companion meeting is recorded, will be available to SH members post meeting

🩸TdT has been proposed to be involved in the generation of FLT3-ITD and NPM1 mutations in AML (below example of NPM1 mutated AML with FLT3-ITD mutation and TDT overexpression by IHC) #hemepath #leusm #bmtsm

"Molecular Diagnostic Outcomes from 700 Cases: What Can We Learn from a Retrospective Analysis of Clinical Exome Sequencing?". New #OpenAccess article from multiple @AMPath member authors. Full FREE text: jmdjournal.org/article/S1525-…

Self portrait at the dressing table, 1909 by painter Zinaida Yevgenyevna Serebriakova, born in Ukraine #WomensArt

Just a pretty #meningioma

In honor of #ColorectalCancerAwarenessMonth, we're pleased to share AMP's free "Molecular in My Pocket" guide on molecular biomarkers in #colorectalcancer: ow.ly/Tlez50IamtH #molpath #oncology